Supreme Court Won't Hear Patent Dispute Over Cox-2 Inhibitors

Law360, New York (November 30, 2004, 12:00 AM EST) -- The U.S. Supreme Court has refused to hear the University of Rochester’s appeal in its patent dispute with makers of cox-2 inhibitor pain killers, ending a legal battle that has cost the school $10 million.

Without explanation, the high court denied the school's request for a review of lower court rulings that dismissed its patent infringement claims against Pfizer Inc. and Merck & Co. over the class of anti-inflammatory drugs.

"We are, of course, very disappointed in the Supreme Court's decision," University of Rochester President Thomas...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.